10-Q//Quarterly update
GELTEX PHARMACEUTICALS INC 10-Q
Accession 0000950135-00-005084
CIK 0001001425operating
Filed
Nov 13, 7:00 PM ET
Accepted
—
Size
301.1 KB
Accession
0000950135-00-005084
Documents
- 10-Qb37214gpe10-q.txtPrimary
GELTEX PHARMACEUTICALS INC.
- EX-10.1b37214gpex10-1.txt
MANUFACTURING AND SUPPLY AGREEMENT
- EX-10.2b37214gpex10-2.txt
GLOBAL MANUFACTURING AND SUPPLY AGREEMENT
- EX-10.3b37214gpex10-3.txt
LETTER AGREEMENT WITH MARK SKALETSKY
- EX-10.4b37214gpex10-4.txt
LETTER AGREEMENT WITH STEVEN BURKE
- EX-10.5b37214gpex10-5.txt
LETTER AGREEMENT WITH MARTHA CARTER
- EX-10.6b37214gpex10-6.txt
LETTER AGREEMENT WITH PAUL MELLET, JR.
- EX-10.7b37214gpex10-7.txt
LETTER AGREEMENT WITH TIMOTHY NOYES
- EX-10.8b37214gpex10-8.txt
LETTER AGHREEMENT WITH EDMUND SYBERTZ
- EX-10.9b37214gpex10-9.txt
LETTER AGREEMENT WITH JOSEPH TYLER
- EX-27.1b37214gpex27-1.txt
FINANCIAL DATA SCHEDULE
Issuer
GELTEX PHARMACEUTICALS INC
CIK 0001001425
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001001425
Filing Metadata
- Form type
- 10-Q
- Filed
- Nov 13, 7:00 PM ET
- Size
- 301.1 KB